Delivery Order SPE2DB22D3004-SPE2DB25FPH13

Award Date 1/29/25
Potential Completion Date 1/30/25
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,224.36 for the supply of Repatha 140 mg/ml SureClick medication. The contract is a firm fixed-price agreement and has an ultimate completion date of November 29, 2023. The award was made by the Defense Logistics Agency (DLA), a defense agency, and is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to deliver Repatha 140 mg/ml SureClick medication. The contract, valued at $1,355.76, is a Delivery Order awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of October 28, 2024. The contract type is Firm Fixed Price, and there is no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,050.46 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Repatha 140 mg/mL SureClick medication. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, valued up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for AmerisourceBergen to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,051.98 firm-fixed-price delivery order is for the supply of Repatha 140 mg/mL SureClick medication. The contract has an ultimate completion date of January 14, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
The U.S. Department of Defense, through the Defense Logistics Agency (DLA) Troop Support Medical, awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $2,033.64 contract is for the provision of Repatha 140 mg/mL SureClick injectable medication. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, valued at up to $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,474.00 Firm Fixed Price delivery order is for the supply of Repatha 140 mg/ml SureClick medication and has an ultimate completion date of April 4, 2022. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,100.38 firm fixed-price delivery order is for the supply of Repatha 140 mg/mL SureClick medication. The contract has a completion date of May 3, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of the medication Repatha (140 mg/ml SureClick) to the Defense Logistics Agency (DLA). The Delivery Order is valued at $4,207.92 and has a firm fixed price. The contract has an ultimate completion date of December 16, 2024. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not designated with any set-aside requirements, indicating open competition. The contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,131.48 firm fixed-price delivery order is for the supply of Repatha 140 mg/mL SureClick medication. The contract has an ultimate completion date of December 16, 2024 and was awarded on December 13, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, to provide Repatha 140 mg/mL SureClick medication. The $1,298.23 order has a completion date of February 14, 2024 and was awarded on February 13, 2024. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FPH13
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp (Amerisourcebergen) is for the delivery of Repatha 140 mg/mL SureClick medication, valued at $2,103.96. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, with an ultimate completion date of January 30, 2025. This is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This particular delivery order does not have a set-aside designation, indicating open competition.

Generated 4/30/25, 10:01 AM